Clinical Trials Logo

Eczema clinical trials

View clinical trials related to Eczema.

Filter by:

NCT ID: NCT00442091 Completed - Clinical trials for Vesicular Palmoplantar Eczema

Dandelion Juice in the Treatment of Dyshidrotic Hand Eczema

Start date: December 2010
Phase: N/A
Study type: Interventional

Dandelion juice has been used in herbal medicine for at least 1000 years. Vesicular hand eczema is a rare, but difficult to treat, type of hand eczema. One case report has shown that ingestion of dandelion juice could induce a beneficial effect on this type of eczema. The purpose of this study is to test whether this effect can be retrieved in other patients.

NCT ID: NCT00438646 Completed - Asthma Clinical Trials

Oral Bacteria and Allergic Disease in Children

Start date: February 2007
Phase: N/A
Study type: Observational

This study will see if bacteria differ between children who have allergies or asthma and children who do not have allergies or asthma. Previous research suggests that some bacteria may protect against allergies and asthma. This study may provide more information on why some children develop allergies and asthma. Patients at the University of North Carolina-Chapel Hill School of Dentistry who are between 6 and 11 years of age may be eligible for this study. Parents of participating children complete a questionnaire about the child and the child's health. The child provides a saliva sample by chewing a small piece of wax and spitting in a cup. The saliva sample is analyzed in the laboratory for bacteria, yeast and antibodies (substances the body produces to fight germs).

NCT ID: NCT00438022 Completed - Atopic Dermatitis Clinical Trials

Identifying Risk Factors for Eczema Herpeticum in Individuals With Atopic Dermatitis

Start date: March 2006
Phase: N/A
Study type: Observational

Atopic Dermatitis (AD), also known as eczema, is a skin disease that causes the skin to be hot, dry and scaly, and have severe itching. There are different kinds of eczema. Eczema herpeticum (EH) is a type of eczema that spreads due to an underlying herpes virus infection. The purpose of this research study is to identify the risk factors that may cause EH.

NCT ID: NCT00419406 Completed - Atopic Dermatitis Clinical Trials

Medium-Dose UVA1 Versus Narrow-Band UVB in Atopic Dermatitis

Start date: March 2005
Phase: N/A
Study type: Interventional

Atopic dermatitis (AD) is a very common disorder that is characterized by pruritic inflammatory skin lesions, with patients usually having an individual or family history of atopic diseases in their background. Phototherapy is among the first-line approaches in the management of AD. In this context, a variety of studies have shown a beneficial effect of natural or artificial UV radiation in atopic dermatitis (AD). The past ten years have seen the introduction of new phototherapeutic regimens for AD, including UVA1 and NB-UVB.UVA1 seems to be more effective than the above mentioned broadband spectra, in particular in acute severe AD. The aim of the present study is the comparison of UVA1 and NB-UVB phototherapy in the treatment of AD. Additionally, the course of several cytokines, human beta-defensins, and SMAD-proteins will be evaluated during the course of treatment.

NCT ID: NCT00407979 Completed - Psoriasis Clinical Trials

Comparison of Cathelicidin Expression in Skin and Saliva in Patients With Atopic Dermatitis and Psoriasis

Start date: July 2005
Phase: N/A
Study type: Observational

Cathelicidins are small proteins in the human body that protect against infection. The purpose of this study is to determine if the amount of cathelicidins and other small proteins found in saliva can predict the amount of these in the skin of people who have acute atopic dermatitis (AD) or psoriasis.

NCT ID: NCT00407069 Completed - Atopic Dermatitis Clinical Trials

Role of Antimicrobial Peptides in Host Defense Against Vaccinia Virus

Start date: June 2005
Phase: N/A
Study type: Observational

Atopic dermatitis (AD) is a chronic inflammatory skin disorder characterized by recurrent viral skin infections. Recent studies have demonstrated that the skin of people with AD my have decreased antimicrobial peptide (AMP) expression. The purpose of this study is to compare smallpox virus replication and the number of AMPs and other antiviral molecules in people with AD, as compared to those seen in people with psoriasis or asthma, or healthy individuals.

NCT ID: NCT00406081 Completed - Atopic Dermatitis Clinical Trials

Immune Response to Varicella Vaccination in Children With Atopic Dermatitis

Start date: December 2005
Phase: N/A
Study type: Observational

Atopic dermatitis (AD) causes people to be susceptible to skin infection and inflammations. The purpose of this study is to determine the immune response to chicken pox vaccine in children with or without AD who received the vaccine 2 to 16 weeks prior to the study visit.

NCT ID: NCT00404196 Completed - Hand Eczema Clinical Trials

LEO19123 Cream in the Treatment of Hand Eczema

Start date: October 2006
Phase: Phase 2
Study type: Interventional

To compare the efficacy and safety of two different dose combinations of LEO19123 cream (calcipotriol and LEO80122) with LEO19123 cream vehicle for 3 weeks in the treatment of patients with hand eczema.

NCT ID: NCT00392067 Completed - Atopic Dermatitis Clinical Trials

LEO19123 Cream in the Treatment of Atopic Dermatitis

Start date: October 2006
Phase: Phase 2
Study type: Interventional

To compare the efficacy and safety of two different dose combinations of LEO19123 (calcipotriol and LEO80122) with LEO19123 cream vehicle for 3 weeks in the treatment of patients with atopic dermatitis

NCT ID: NCT00379678 Completed - Atopic Dermatitis Clinical Trials

Effects of Pimecrolimus on Skin Biopsy Ex-plants From Patients With Atopic Dermatitis

Start date: September 2006
Phase: N/A
Study type: Observational

THe study seeks to determine if pimecrolimus has a positive effect on increasing antimicrobial peptide expression and reducing vaccinia virus growth in the skin explants from patients with atopic dermatitis.